Istituto Romagnolo per lo Studio dei Tumors "Dino Amadori"

Site:	Istituto Romagnolo per lo Studio dei Tumors "Dino Amadori"
Address:
City:	Meldola
State:	FC
Zip:	47014
Country:	Italy

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
3	A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3)	Recruiting	Active	IDRX-42	NCT07218926
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Active, not recruiting	Active, not recruiting	Bezuclastinib plus Sunitinib	NCT05208047